PTC Therapeutics
Price & Volume
Stats
See more52W Range | $35.95-$87.50 |
Market Cap | $5.4B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $1.7B |
Revenue Growth (YoY) | -22.7% |
Gross Profit (12 Mos) | $1.2B |
Diluted EPS | $8.45 |
News
See moreYahoo Finance • 8 days ago
PTC Therapeutics stock down over 2% on worse-than-expected Q4 results, guidance
Yahoo Finance • 15 days ago
PTC Therapeutics drops as it pulls Translarna NDA resubmission
Yahoo Finance • 2 months ago
Royalty Pharma buys remaining royalty interest in Roche drug Evrysdi
Yahoo Finance • 2 months ago
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. Matthew B. Klein F.A.C.S., M.D., M.S. |
Address | 500 Warren Corporate Center Drive, Warren, NJ, United States, 07059 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 991 |
